UDG Healthcare (LON:UDG) had its target price upped by investment analysts at Peel Hunt from GBX 860 ($11.57) to GBX 880 ($11.84) in a report issued on Thursday. The brokerage presently has an “add” rating on the stock. Peel Hunt’s price objective would indicate a potential upside of 3.06% from the stock’s previous close.

UDG has been the subject of several other reports. N+1 Singer reiterated a “hold” rating and set a GBX 770 ($10.36) price objective on shares of UDG Healthcare in a research note on Tuesday, August 15th. Liberum Capital reiterated a “hold” rating and set a GBX 884 ($11.90) price objective on shares of UDG Healthcare in a research note on Wednesday, November 15th. Jefferies Group increased their target price on UDG Healthcare from GBX 830 ($11.17) to GBX 855 ($11.51) and gave the stock a “hold” rating in a report on Wednesday, October 4th. Numis Securities cut UDG Healthcare to a “reduce” rating and set a GBX 765 ($10.30) target price on the stock. in a report on Thursday, November 9th. Finally, Stifel Nicolaus restated a “hold” rating and set a GBX 815 ($10.97) target price on shares of UDG Healthcare in a report on Thursday, November 30th. One equities research analyst has rated the stock with a sell rating and six have issued a hold rating to the company. UDG Healthcare currently has an average rating of “Hold” and a consensus target price of GBX 826.43 ($11.12).

UDG Healthcare (LON UDG) traded down GBX 2.16 ($0.03) during trading on Thursday, reaching GBX 853.84 ($11.49). The company’s stock had a trading volume of 1,270,000 shares, compared to its average volume of 720,200. UDG Healthcare has a 1 year low of GBX 632.50 ($8.51) and a 1 year high of GBX 963 ($12.96).

ILLEGAL ACTIVITY WARNING: “UDG Healthcare (UDG) Price Target Raised to GBX 880” was originally reported by American Banking News and is the sole property of of American Banking News. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The correct version of this story can be accessed at https://www.americanbankingnews.com/2017/12/09/udg-healthcare-udg-price-target-raised-to-gbx-880.html.

UDG Healthcare Company Profile

UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies.

Analyst Recommendations for UDG Healthcare (LON:UDG)

Receive News & Ratings for UDG Healthcare plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UDG Healthcare plc and related companies with MarketBeat.com's FREE daily email newsletter.